Co-Pay Relief Program Announces Assistance for a New Disease Area
Program eases cost burden for patients with pulmonary fibrosis
PAF’s Co-Pay Relief (CPR) program is pleased to announce that assistance will now be available to patients with pulmonary fibrosis through the launch of a new disease fund that can provide direct financial help to qualified patients with co-payments, co-insurance or cost-sharing associated with pharmaceutical treatments and/or prescription medications.
Specific information relative to the pulmonary fibrosis fund is provided below:
Maximum annual award level: $5,000
- Patient must be insured by Medicare, Medicaid, or Military Benefits and insurance must cover the medication for which patient seeks assistance.
- Patient must have a confirmed diagnosis of Pulmonary Fibrosis.
- Patient must reside and receive treatment in the United States.
- Patient’s income must fall below 400% of the Federal Poverty Guideline(FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.
The Co-Pay Relief Program may help with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition and theprogram provides assistance to patients on a first-come, first-serve basis and processes applicants in the order in which their completed applications are received.
For personal assistance with the application process please contact us toll free at 866-512-3861.